跳至主要内容
临床试验/NCT04927039
NCT04927039Unknown不适用

Effects of Iloprost on Oxygenation During One-lung Ventilation in Supine-positioned Patients

Yonsei University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
PaO2 (partial pressure of arterial oxygen) to FiO2 (fraction of inspired oxygen) ratio (P/F ratio)

研究概览

简要总结

One-lung ventilation (OLV) is essential during mediastinal mass excision. However, OLV induces a drastic increase of intrapulmonary shunt due to maintained pulmonary perfusion through the nonventilated lung. In addition, it is reported that supine positioning of patient during OLV, which is required during mediastinal mass excision, results in worse oxygenation than lateral decubitus positioning.

Iloprost is a prostaglandin analogue and when inhaled during OLV, it acts selectively on the pulmonary vasculature, reducing pulmonary vascular resistance of well-ventilated lung and thereby alleviating ventilation-perfusion mismatch. The purpose of this study is to evaluate the effects of inhaled iloprost on oxygenation during one-lung ventilation in patients undergoing mediastinal mass excision.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for Video-assisted thoracoscopic surgery (VATS) mediastinal mass excision
  • Patient age from 20 to 80
  • American Society of Anaesthesiologists (ASA) physical status classification II~III

排除标准

  • Chronic obstructive pulmonary disease (COPD) with Forced expiratory volume in 1 second (FEV1) to Forced vital capacity (FVC) ratio < 0.7 and percentage of predicted FEV1 ≤ 80%
  • Diffusing capacity of carbon monoxide (DLCO) < 80%
  • Aspartate transaminase (AST) level ≥100 IU/mL or alanine transaminase (ALT) ≥ level 50 IU/L
  • Creatinine clearance ≤ 30mL/min
  • Congestive heart failure, arrhythmia
  • Unstable angina, coronary artery occlusive disease (CAOD), history of myocardial infarction within 6 months
  • Pulmonary edema, pulmonary arterial hypertension
  • Allergic to prostaglandin or prostacyclin analogue
  • Patients with peptic ulcer bleeding, trauma, intracranial hemorrhage
  • History of cerebrovascular disease (e.g. transient ischemic attack, stroke) within 3 months
  • Valvular heart disease
  • Pregnant women

研究组 & 干预措施

Control group

Placebo Comparator

干预措施: 5ml of inhaled normal saline (Drug)

Iloprost group

Experimental

干预措施: 20μg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled normal saline (Drug)

结局指标

主要结局

PaO2 (partial pressure of arterial oxygen) to FiO2 (fraction of inspired oxygen) ratio (P/F ratio)

时间窗: Twenty minutes after the completion of drug inhalation

The P/F ratio is a widely-used objective tool to identify hypoxemic respiratory failure when supplemental oxygen has been administered. It can be used to evaluate the effect of iloprost on oxygenation during OLV.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effects of Iloprost on Oxygenation During One-lung... | 临床试验